The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Open Access
- 7 July 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 27 (19), 5430-5439
- https://doi.org/10.1158/1078-0432.ccr-21-0005
Abstract
Purpose: Structural variants (SV) of the MYC gene region are common in multiple myeloma (MM) and influence disease progression. However, the prognostic significance of different MYC SVs in MM has not been clearly established. Experimental design: We conducted a retrospective study of MM comparing MYC SV subtypes identified by next generation sequencing (NGS) and fluorescence in situ hybridization (FISH) to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study. Results: MYC SVs were found in 41% of cases and were classified into 9 subtypes. A correlation between the presence of a MYC SV and increased MYC expression was identified. Among the 9 MYC subtypes, the non-Ig insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared to other MYC SV subtypes. Although the FISH methodology failed to detect ~70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared to other MYC subtypes. Conclusion: Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in MM. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the MM clone.Keywords
Funding Information
- NIH (P50CA186781)
This publication has 43 references indexed in Scilit:
- Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patientsBlood Cancer Journal, 2014
- MYCstatus determination in aggressive B-cell lymphoma: the impact of FISH probe selectionHistopathology, 2013
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myelomaLeukemia, 2011
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testingCancer Genetics and Cytogenetics, 2010
- Circos: An information aesthetic for comparative genomicsGenome Research, 2009
- Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseHaematologica, 2009
- AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center MalignanciesCancer Cell, 2008
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeBlood, 2007
- Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.Proceedings of the National Academy of Sciences of the United States of America, 1990